Status:
ENROLLING_BY_INVITATION
Far-Infrared Socks for Neuropathic Pain and Nerve Function in Diabetic Patients
Lead Sponsor:
TC Erciyes University
Conditions:
Diabetic Peripheral Neuropathy (DPN)
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study aims to evaluate the effectiveness of far-infrared radiation (FIR) emitting socks in improving neuropathic pain, nerve conduction, and quality of life in patients with diabetic peripheral n...
Eligibility Criteria
Inclusion
- Diagnosed with diabetic peripheral neuropathy (DPN) with mild to moderate severity based on clinical evaluation.
- Oriented to person, place, and time (cognitively intact).
- Residing in Kayseri and receiving treatment in the city.
- HbA1C level below 8.5% during the study period.
- Non-smoker for at least 6 months.
- Not using neuropathic pain medication for at least 3 months before enrollment.
- Body Mass Index (BMI) between 25 - 35.
- Able to be contacted by phone for follow-up.
- Willing to participate and provide informed consent.
Exclusion
- Presence of diabetic foot ulcers.
- Non-mobilized individuals (unable to walk independently).
- Severe peripheral artery disease (Ankle Brachial Index (ABI) \< 0.4).
- Liver failure or renal failure (dialysis patients).
- Coronary artery disease.
- Candidates for surgery during the intervention period.
- Lower extremity arthroplasty or orthosis indication during the intervention period.
- Neurological or cognitive impairments (e.g., dementia, Alzheimer's disease).
- Receiving non-pharmacological treatment for diabetic peripheral neuropathy (DPN).
- Chronic alcohol or substance use.
- Severe anemia, vitamin B12 deficiency, or iron deficiency anemia.
- Recent changes in diabetes medication or newly diagnosed with diabetes.
- Neurological, cardiovascular, or orthopedic damage affecting the lower extremities.
- Use of cytotoxic or immunosuppressive agents or history of radiation therapy.
- Pregnant, breastfeeding, or attempting to conceive.
- Receiving physiotherapy at any point during the study period.
Key Trial Info
Start Date :
February 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06880484
Start Date
February 2 2025
End Date
June 30 2026
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erciyes Üniversitesi
Talas, Kayseri, Turkey (Türkiye), 38280